Skip to content
★ Sign in to follow
LC

Lady C Witty

CEO
GlaxoSmithKline plc
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 14 Oct 2016 for GlaxoSmithKline plc, €845.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Lady C Witty: trading record in brief

Lady C Witty appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Between 14 July 2016 and 14 October 2016, the trades on record add up to 4 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 14 October 2016 came the latest disclosure, a share grant for €845 in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Lady C Witty

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    PCA of Sir Andrew Witty (Chief Executive Officer)ExecutivesGlaxoSmithKline plc
    764 GBP7FCA-NSM
    45 shares@ £16.98441.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171320_013001980_20200330143616319_11066-3
  • ◆
    PCA of Sir Andrew Witty (Chief Executive Officer)ExecutivesGlaxoSmithKline plc
    32,323 GBP12FCA-NSM
    1,897 shares@ £17.038947.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171057_013001974_20200330143616319_11065-2
  • ◆
    PCA of Sir Andrew Witty (CEO)ExecutivesGlaxoSmithKline plc
    31,948 GBP27FCA-NSM
    1,926 shares@ £16.587550.6% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718165806_012896740_20200330143558405_13589
  • ◆
    PCA of Sir Andrew Witty (CEO)ExecutivesGlaxoSmithKline plc
    752 GBP22FCA-NSM
    46 shares@ £16.341.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718165020_012896729_20200330143558405_13585

4 of 4 declarations